Biocept Company
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
%20.jpg)
Founded Date:
01.01.1993
Total Funding:
$43.2M
Investor Type:
For Profit
Employee Number:
51-100
Funding Status:
IPO
Technology:
Сancer Diagnostics
Last Funding Type:
Post-IPO Equity
Investors Number:
3
Industry:
Deep Diagnostics
Headquarters:
San Diego, California, United States
Estimated Revenue:
$1M to $10M